Onconova Therapeutics, Inc. Announces Timing for Second Quarter 2014 Financial Results and Conference Call

NEWTOWN, Pa., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that financial results for the Company's second quarter ended June 30, 2014 will be released on Wednesday, August 13, 2014. The Company will host a conference call and audio webcast at 4:30 PM ET on the same day.

Conference Call and Webcast Details:

A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the Company's website for two weeks following the call.

About Onconova Therapeutics, Inc.

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer. Onconova's clinical and pre-clinical stage drug development candidates are derived from its extensive chemical library and are designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. In addition to rigosertib, the Company's most advanced product candidate, two other candidates are in clinical trials, and several candidates are in pre-clinical stages.  For more information, please visit http://www.onconova.com.

CONTACT: Onconova Therapeutics

         Benjamin Hoffman, 267-759-3680

         bhoffman@onconova.us

         

         or

         

         Media:

         MacDougall Biomedical Communications

         Chris Erdman, 781-235-3060

         chris@macbiocom.com